AOD 9604 is a synthetic peptide fragment studied for fat loss. Learn how it works, research findings, safety concerns, and why it's not FDA-approved.
AOD 9604 is a synthetic peptide fragment of human growth hormone (hGH 176-191) that researchers have studied for its potential effects on fat metabolism. It is also known as the AOD-9604 peptide or simply the peptide AOD 9604. Research suggests it may stimulate lipolysis (fat breakdown) and inhibit lipogenesis (fat storage), but AOD 9604 is not FDA-approved for human use, and its effectiveness and safety remain uncertain.
What Is AOD 9604?
AOD 9604 is a modified piece of the C-terminal end of human growth hormone. Scientists developed it in the 1990s as a potential treatment for obesity and related metabolic conditions. Unlike full hGH, it is designed to target fat cells without affecting blood sugar or promoting muscle growth.
Other names for this compound include AOD9604, AOD-9604, and hGH fragment 176-191. AOD 9604 what is it? Essentially, it is a research peptide that has been investigated in clinical trials but never received regulatory approval for any human medical use.
Because it is not approved, AOD 9604 is sold online as a "research chemical." These products are not intended for human consumption, and their purity and potency are not guaranteed by the FDA.
AOD 9604 is typically sold as a lyophilized powder in small vials. It is not a dietary supplement, and it is not approved for any medical condition. The lack of regulation means that product quality can vary widely between vendors.
How Does AOD 9604 Work?
The AOD 9604 mechanism of action is thought to involve mimicking part of hGH's fat-burning effects. Specifically, it may bind to receptors on fat cells and trigger lipolysis, the breakdown of stored fat into free fatty acids. It may also reduce lipogenesis, the process by which the body creates new fat cells.
Unlike full growth hormone, AOD 9604 does not appear to significantly raise IGF-1 levels or affect insulin sensitivity in the same way. This selectivity is why some researchers hoped it could offer fat loss without the side effects of hGH therapy.
However, how does AOD 9604 work in humans is still not fully understood. Study results have been mixed, and no large-scale, long-term trials have confirmed its effectiveness for weight loss.
Some studies suggest that AOD 9604 may increase fat oxidation and energy expenditure. However, these effects have been observed mainly in animal models or small human trials, and the results have not been consistently replicated.
AOD 9604 Uses and Research Findings
AOD 9604 uses in research have focused primarily on obesity and fat reduction. Some clinical trials in the 2000s showed modest weight loss, but the results were not strong enough to gain regulatory approval. Other studies have explored its potential for osteoarthritis and cartilage repair, though evidence is limited.
Many people search for aod 9604 for weight loss based on anecdotal reports and online marketing. However, the scientific consensus is that more high-quality human trials are needed before any firm conclusions can be drawn. Online user reports often describe mixed results, with some people reporting fat loss and others seeing little change.
One of the most cited human trials involved obese adults and found that AOD 9604 produced a small but statistically significant reduction in body fat compared to placebo. Even so, the weight loss was modest and not clinically meaningful for most participants.
It is important to note that AOD 9604 is not a cure for obesity or a substitute for diet and exercise. Anyone considering it should consult a healthcare professional first.
AOD 9604 Dosage, Reconstitution, and Administration
There is no standardized aod 9604 dosage for human use because the peptide is not approved for medical purposes. In research settings, doses have ranged from 250 mcg to 1 mg per day, often given via subcutaneous injection. These doses are not recommendations and should not be used as guidance for self-administration.
The process of aod 9604 reconstitution involves mixing the lyophilized powder with bacteriostatic water. This step requires careful measurement and sterile technique. Incorrect reconstitution can lead to dosing errors or contamination.
Frequency of administration in research has varied from once daily to multiple times per week. There is no consensus on the optimal dose, timing, or duration of use, and self-dosing is strongly discouraged.
Some users combine AOD 9604 with other compounds, such as tirzepatide, but there is no clinical evidence supporting these combinations. Such practices carry unknown risks and should only be done under medical supervision.
How AOD 9604 Compares to Other Peptides
When comparing aod 9604 vs tesamorelin, it is helpful to look at their approved uses and mechanisms. Tesamorelin is FDA-approved for HIV-associated lipodystrophy, while AOD 9604 is not approved for any condition. Tesamorelin works by stimulating growth hormone release, whereas AOD 9604 acts directly on fat cells.
Another compound sometimes mentioned is MOTS-c. MOTS-c is a mitochondrial-derived peptide studied for metabolic regulation, while AOD 9604 is a growth hormone fragment. They have different mechanisms, and neither is approved for weight loss in the general population.
| Peptide | Origin | Approved Use | Primary Mechanism |
|---|---|---|---|
| AOD 9604 | hGH fragment 176-191 | None | Stimulates lipolysis, inhibits lipogenesis |
| Tesamorelin | GHRH analog | HIV-associated lipodystrophy | Stimulates growth hormone release |
| MOTS-c | Mitochondrial-derived peptide | None | Regulates metabolic homeostasis |
Safety, Side Effects, and Legal Status
Research on aod 9604 benefits and side effects has been conducted in short-term trials. Commonly reported side effects include injection site reactions, headache, and nausea. Long-term safety data are lacking, and the peptide's effects on hormone levels, cardiovascular health, and cancer risk are not well understood.
Because AOD 9604 is a peptide, there is also a risk of immune reactions. Some users have reported swelling, redness, or pain at the injection site. More serious reactions are possible but not well documented.
AOD 9604 is not FDA-approved for human use in the United States. It is legal to purchase as a research chemical for laboratory studies, but it is illegal to sell it as a drug or supplement for human consumption. The FDA has issued warnings about unapproved peptides sold online.
Anyone considering AOD 9604 should talk to a licensed healthcare provider. Self-administering unapproved peptides can lead to serious health consequences, including infections, allergic reactions, and hormonal imbalances.
Bottom Line
AOD 9604 is an investigational peptide fragment of human growth hormone that has shown some promise for fat loss in early research. However, it is not FDA-approved, has not been proven safe or effective for human use, and should not be used without medical supervision. If you are interested in weight loss treatments, speak with a healthcare professional about approved options.
Frequently Asked Questions
Does AOD 9604 work for weight loss?
Research on AOD 9604 for weight loss has shown modest fat reduction in some small human trials, but the results are not consistent or strong enough for FDA approval. AOD 9604 is not a proven weight loss treatment, and it should not replace diet, exercise, or approved medications. Talk to a doctor about safe and effective options.
What is AOD 9604 peptide used for?
AOD 9604 is primarily studied for obesity and fat metabolism, and some early research has looked at its use for osteoarthritis. It is not approved for any human medical condition in the United States. Any use outside of research is experimental and carries unknown risks.
Is AOD 9604 safe?
Short-term studies of AOD 9604 report side effects such as injection site reactions, headache, and nausea. Long-term safety data are not available, and the peptide's effects on hormones and overall health are not fully understood. AOD 9604 is not FDA-approved, so its safety and purity cannot be guaranteed.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.